Actinium Pharmaceuticals ...
(ATNM)
undefined
undefined%
At close: undefined
1.39
0.36%
After-hours Jan 07, 2025, 08:00 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 |
| PE Ratio | -2.77 | -8.05 | -5.03 | -4.29 | -1.5 | -1.73 | -1.67 | -1.74 | -5.86 | -6.53 | -12.44 | -0.2 | 116.89 | 10.00K | -749.29 | -535.55 | -1.13K | -188.26 |
| PS Ratio | 1.67K | 249.62 | 108.06 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PB Ratio | 3.72 | 3.87 | 1.68 | 1.54 | 5.76 | 4.66 | 3.24 | 2.35 | 5.61 | -83.83 | -85.93 | 1.44 | -14.26 | -176.84 | -173.77 | -226.23 | -503.92 | -188.26 |
| P/FCF Ratio | -2.85 | 31.06 | -5.89 | -4.33 | -1.51 | -1.99 | -2.05 | -2.03 | -6.63 | -11.11 | -21.24 | -0.32 | 2.23K | 2.14K | -890.82 | -1.20K | -1.08K | -246.88 |
| P/OCF Ratio | -2.86 | 29.74 | -5.92 | -4.38 | -1.51 | -1.99 | -2.06 | -2.04 | -6.65 | -11.23 | -21.3 | -0.32 | 2.23K | 2.14K | -890.82 | -1.20K | -1.08K | -246.88 |
| OCF/S Ratio | -584.38 | 8.39 | -18.24 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | n/a | 0.01 | 0.00 | 0.01 | 0.07 | 0.03 | n/a | n/a | 0.01 | -0.15 | -0.1 | 0.12 | -1.47 | -0.62 | -0.71 | -0.67 | -1.08 | -0.79 |
| Quick Ratio | 9.21 | 10.44 | 11.66 | 13.62 | 1.89 | 2.36 | 3.82 | 4.95 | 5.74 | 0.78 | 0.79 | 1.25 | 0.01 | 0.00 | 0.07 | 0.08 | 1.75 | 0.11 |
| Current Ratio | 9.21 | 10.44 | 11.66 | 13.62 | 1.89 | 2.36 | 3.82 | 4.95 | 5.74 | 0.78 | 0.79 | 1.25 | 0.01 | 0.00 | 0.07 | 0.08 | 1.75 | 0.11 |
| Asset Turnover | 0.00 | 0.01 | 0.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Interest Coverage | n/a | n/a | n/a | n/a | n/a | -137.44 | -4.96K | -5.36K | -3.16K | -25.96K | -2.63K | -7.23 | -2.09 | -3.93 | -2.5 | -5.48 | -4.27 | -20.15 |
| Return on Equity (ROE) | -1.34 | -0.48 | -0.33 | -0.36 | -3.85 | -2.68 | -1.95 | -1.35 | -0.96 | 12.84 | 6.91 | -7.3 | -0.12 | -0.02 | 0.23 | 0.42 | 0.45 | 1.00 |
| Return on Assets (ROA) | -0.6 | -0.28 | -0.31 | -0.33 | -1.86 | -1.59 | -1.45 | -1.08 | -0.79 | -3.26 | -1.87 | -1.44 | 68.59 | 11.16 | -10.52 | -14.09 | -2.3 | -39.49 |
| Return on Capital (ROIC) | -0.71 | -0.33 | -0.34 | -0.36 | -3.49 | -2.7 | -1.97 | -1.49 | -1.13 | 11.69 | 4.23 | -6.94 | 0.38 | 0.73 | 0.58 | 1.09 | -4.35 | 4.49 |
| Dividend Yield | n/a | n/a | n/a | 0.00 | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | -0.00 | -0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 100.00% | 32.14% | 54.20% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Net Profit Margin | -60.27K% | -3.10K% | -2.15K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | -60.27K% | -3.21K% | -2.17K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit Margin | -64.10K% | -3.31K% | -2.18K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| FCF Margin | -58.63K% | 803.69% | -1.84K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| EBITDA Margin | -63.12K% | -3.24K% | -2.14K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |